Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 1929273PMCID PMC284322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus

  1990cited by this paper
• Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility

  1990cited by this paper
• Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase

  1990cited by this paper
• Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats

  1987cited by this paper
• Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase.

  1987cited by this paper
• Comparing the means of several groups.

  1986cited by this paper
• Statistics in practice. Comparing the means of several groups.

  1985cited by this paper

• Piperacillin/tazobactam selects an ampC derepressed E. cloacae complex mutant in a diabetic osteoarticular infection.

  2020cites this paper
• Management of infections caused by extended-spectrum β–lactamase-producing Enterobacteriaceae: current evidence and future prospects

  2018cites this paper
• Antimicrobial Resistance Salmonella enterica serovar 1,4,[5],12:i:- isolated from patients in Thailand

  2017influential citation
• The Use of Noncarbapenem &bgr;-Lactams for the Treatment of Extended-Spectrum &bgr;-Lactamase Infections

  2017cites this paper
• Clinical Management of Infections Caused by Enterobacteriaceae that Express Extended-Spectrum β-Lactamase and AmpC Enzymes

  2015cites this paper
• Modified Double Disc Synergy Test to Detect ESBL Production in Urinary Isolates of Escherichia coli and Klebsiella pneumoniae.

  2013cites this paper
• Extended Spectrum β-Lactamase (ESBL)-Producing Enterobacteriaceae

  2012cites this paper
• In vitro efficiency of the piperacillin/tazobactam combination against inhibitor-resistant TEM- and complex mutant TEM-producing clinical strains of Escherichia coli.

  2011cites this paper
• Extended-spectrum β-lactamases in Gram Negative Bacteria

  2010cites this paper
• EVALUATION OF SUB-ACUTE TOXICITY PROFILE OF FIXED DOSECOMBINATION OF MEROPENEM AND SULBACTAM IN WISTAR RATS

  2010cites this paper
• Detection of extended spectrum beta-lactamase production in clinical isolates of Klebsiella spp.

  2008cites this paper
• ESBLs detection in clinical microbiology: why & how?

  2008cites this paper
• Clinical significance of extended-spectrum beta-lactamases

  2006cites this paper
• Uncorrected proofs — not for distribution 5 A Latin American “ Point de Vue ” on the Epidemiology , Control , and Treatment Options of Infections Caused by Extended-spectrum Beta-lactamase Producers

  2006cites this paper
• Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.

  2006cites this paper
• Development of a diagnostic microarray for the rapid detection of extended spectrum beta-lactamases for the use in clinical microbiology

  2005cites this paper
• Extended-Spectrum β-Lactamases: a Clinical Update

  2005cites this paper
• CTX-M: changing the face of ESBLs in the UK.

  2005cites this paper
• ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital.

  2004cites this paper
• Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase.

  2004cites this paper
• Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.

  2004cites this paper
• Prevalence of clinical strains resistant to various beta-lactams in a tertiary care hospital in India.

  2004cites this paper
• Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control.

  2003cites this paper
• Ambler Class A Extended-Spectrum β-Lactamases in Pseudomonas aeruginosa: Novel Developments and Clinical Impact

  2003cites this paper
• Hospital-acquired infections in the neonatal intensive care unit--Klebsiella pneumoniae.

  2002cites this paper
• Bacteremia Caused by Escherichia coli producing Extended-spectrum Beta-lactamase: a Case-control Study of Risk Factors and Outcomes

  2002cites this paper
• In vitro and in vivo activities of ciprofloxacin and levofloxacin against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.

  2002cites this paper
• Evolution and clinical importance of extended-spectrum beta-lactamases.

  2001cites this paper
• Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory

  2001cites this paper
• Hospital outbreak of MEN-1-derived extended spectrum β-lactamase-producing Klebsiella pneumoniae

  2001cites this paper
• Therapeutic Challenges Associated with Extended‐Spectrum, β‐Lactamase‐Producing Escherichia coli and Klebsiella pneumoniae

  2001cites this paper
• Extended-spectrum beta-lactamases: epidemiology, detection, and treatment.

  2001cites this paper
• Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms.

  2001cites this paper
• Detection of beta-lactamase-mediated resistance.

  2001cites this paper
• Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat

  2001cites this paper
• Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing SHV extended-spectrum beta-lactamases.

  2001cites this paper
• An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase.

  2001cites this paper
• Cross-resistance patterns among clinical isolates of Klebsiella pneumoniae with decreased susceptibility to cefuroxime.

  2000cites this paper
• beta -Lactamases: which ones are clinically important?

  2000cites this paper
• Treatment options for extended-spectrum beta-lactamase-producers.

  2000cites this paper
• Emerging issues in antibiotic resistance in blood-borne infections.

  2000cites this paper
• Therapeutic Considerations in the Treatment of Respiratory Infections Caused by Ceftazidime-Resistant Klebsiella Pneumoniae

  2000cites this paper
• Detection of Extended-Spectrum β-Lactamases in Klebsiellae with the Oxoid Combination Disk Method

  2000cites this paper
• Successful Interventions for Gram‐Negative Resistance to Extended‐Spectrum β‐Lactam Antibiotics

  1999cites this paper
• Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.

  1999cites this paper
• Nosocomial Outbreak of Cross-Infection due to Multiple-Antibiotic-Resistant Klebsiella pneumoniae: Characterization of the Strain and Antibiotic Susceptibility Studies

  1999cites this paper
• The red menace: Emerging issues in antimicrobial resistance in gram-negative bacilli

  1999cites this paper
• Resistance issues and treatment implications: pneumococcus, Staphylococcus aureus, and gram-negative rods.

  1998cites this paper
• Extended spectrum beta-lactamases.

  1998cites this paper
• Clinical strategies for serious infection: a European perspective.

  1998cites this paper
• Beta-lactamase-mediated resistance and opportunities for its control.

  1998cites this paper
• Trends in beta-lactam resistance among Enterobacteriaceae.

  1998cites this paper
• Bactericidal activity of three beta-lactams alone or in combination with a beta-lactamase inhibitor and two aminoglycosides against Klebsiella pneumoniae harboring extended-spectrum beta-lactamases.

  1998cites this paper
• Sporadic Emergence of Klebsiella pneumoniae Strains Resistant to Cefepime and Cefpirome in Greek Hospitals

  1998cites this paper
• [Comparative activity of cefepime, ceftazidime and imipenem in a mouse infection caused by Klebsiella pneumoniae producing a broad spectrum beta-lactamase].

  1998cites this paper
• Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae.

  1998cites this paper
• Characterization of the extended-spectrum beta-lactamases and determination of the antibiotic susceptibilities of Klebsiella pneumoniae isolates in Hungary.

  1998cites this paper
• Detection of extended-spectrum beta-lactamases. The reliability of methods for susceptibility testing as used in Denmark.

  1998cites this paper
• Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae

  1997cites this paper
• Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center

  1997cites this paper
• Resistance to second- and third-generation cephalosporins among Escherichia coli and Klebsiella species is rare in Finland.

  1997cites this paper
• ESBL-producing organisms and cephalosporins.

  1997cites this paper
• beta-Lactamases: quantity and resistance.

  1997cites this paper
• Emerging antibiotic resistance.

  1997cites this paper
• Cefuroxime resistance in Klebsiella pneumoniae

  1997cites this paper
• Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.

  1996cites this paper
• Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center.

  1996cites this paper
• Is it important to identify extended-spectrum beta-lactamase-producing isolates?

  1996cites this paper
• Are all beta-lactams created equal?

  1996cites this paper
• Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase

  1996cites this paper
• Antimicrobial-drug resistance.

  1996cites this paper
• Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.

  1996cites this paper
• In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase.

  1996cites this paper
• Treatment failure due to extended spectrum beta-lactamase.

  1996cites this paper
• In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins

  1995cites this paper
• beta-Lactamases in laboratory and clinical resistance

  1995cites this paper
• In vivo efficacies of beta-lactam-beta-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniae

  1994cites this paper
• Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases

  1994cites this paper
• Nosocomial Outbreaks of Multiresistant Bacteria: Extended-Spectrum Beta-Lactamases Have Arrived in North America

  1993cites this paper
• Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model

  1993cites this paper
• Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms

  1993cites this paper
• Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests

  1992cites this paper
• More extended-spectrum beta-lactamases

  1991cites this paper